Wednesday, November 5, 2025

Latest

Exxon Warns Exit Without Softer EU Due Diligence Directive

Silver Exports Face Stricter China State Trading

Is The Trump Admin Planning Covert Cartel Strikes In Mexico?

Franco-Nevada Posts Record Revenue In Q3 2025, Tightens GEO Sales Guidance

Glencore Reportedly Closing Canada Copper Hub — Sources

Shopify Q3 2025: Revenue Climbs But Net Income Drops

Denison Mines Denies Claims Made By Saskatchewan First Nation

Antimony Resources Sees Bald Hill Potential Double In Latest Technical Report

Aya Gold & Silver Outlines $1.5 Billion NPV For Boumadine Project

Altman Waves Off Critics On OpenAI’s $1.4T Spending Commitments

Revive Therapeutics

Revive Therapeutics Partners With UCSF To Study Bucillamine For Severe COVID-19

May 3, 2021, 09:24:15 AM

Revive Therapeutics Applies For Orphan Drug Designation For Psilocybin

April 27, 2021, 09:34:32 AM

Revive Therapeutics Files For Patent On Oral Thin Film With Psilocybin

April 22, 2021, 08:18:53 AM

Revive Therapeutics Reports Successful Results Using Psilocybin To Treat Traumatic Brain Injury

March 19, 2021, 07:47:09 AM

Revive Therapeutics To Expand Clinical Sites For Covid-19 Related Phase 3 Study

February 26, 2021, 08:54:19 AM

PharmaTher, Revive, Complete Psilocybin Intellectual Property Transaction

February 17, 2021, 09:58:18 AM

Revive Therapeutics Closes $23.0 Million Bought Deal Financing

February 12, 2021, 11:38:53 AM

Revive Therapeutics Provides Market Update On Cannabinoid Related Research

February 11, 2021, 08:01:25 AM

Revive Therapeutics Doubles Bought Deal Financing To $20.0 Million

January 21, 2021, 10:04:38 AM

Revive Therapeutics Conducts $10.0 Million Bought Deal Financing

January 20, 2021, 08:37:25 PM

Latest News

Tory MP Joins Liberals, Giving Carney Two Seats Away From Majority

Ottawa To Scrap Oil And Gas Cap, Rewrite EV Mandate

SSR Mining Tightens To Lower-Half Guidance As Costs Rise In Q3 2025

Cameco Narrows Sales Guidance On Breakeven Q3 2025

Kinross Gold Sees Earnings Jump 65% In Q3 2025 Despite Output Drop, Higher Costs

Breaking Down Budget 2025: Deficits, Borrowings, Investments

IAMGOLD Q3 2025: Revenue Jumps 61%, Earnings Fall On Impairment

Electra Battery Materials Restarts Construction At Cobalt Refinery

Wesdome Gold Records Free Cash Flow Of $0.52 A Share In Q3 2025

Artemis Gold Posts Q3 Adjusted Net Income Of $141.7 Million In First Full Quarter Of Operations

Video Articles

PMET Resources: Lithium Feasibility Study Sees Economics Tumble

Gold Is Not Rising. Confidence Is Collapsing | Todd “Bubba” Horwitz

IAMGOLD: The Quebec Buying Spree

Recommended

Antimony Resources Sees Bald Hill Potential Double In Latest Technical Report

Altamira Gold Adds Second Drill Rig To Ongoing Exploration Program Targeting Gold Porphyry’s

Trending

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.